Literature DB >> 6132978

Concentration-independent plasma protein binding of benzodiazepines.

L J Moschitto, D J Greenblatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6132978     DOI： 10.1111/j.2042-7158.1983.tb04302.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  27 in total

1.  Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.

Authors:  A Cleton; D Mazee; R A Voskuyl; M Danhof
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Mechanism-based modeling of functional adaptation upon chronic treatment with midazolam.

Authors:  A Cleton; J Odman; P H Van der Graaf; W Ghijsen; R Voskuyl; M Danhof
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

3.  Distribution of diazepam, nordiazepam, and oxazepam between brain extraneuronal space, brain tissue, plasma, and cerebrospinal fluid in diazepam and nordiazepam dependent dogs.

Authors:  E P Wala; W R Martin; J W Sloan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 4.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

5.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

6.  Obesity effects on nitrazepam disposition.

Authors:  D R Abernethy; D J Greenblatt; A Locniskar; H R Ochs; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

7.  Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.

Authors:  J W Mandema; M T Kuck; M Danhof
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

8.  Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; J Wang
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

9.  Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys.

Authors:  H Friedman; D E Redmond; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 10.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.